Stem Cell Treatment
For nearly two years, University of Michigan neurologist Eva Feldman, M.D., has led the nation’s first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig’s disease.
Physicians at Henry Ford Hospital are the first in Michigan in a new national research study to investigate treating a recent heart attack with a patient’s own stem cells to preserve heart muscle function.
At least 300 people attended the weekend’s Second Midwest Conference On Stem Cell Biology and Therapy Friday through Sunday at Oakland University.
Three patients with amyotrophic lateral sclerosis will be permitted to receive a second dose of stem cells delivered directly to the spinal cord, in a clinical trial being led by the University of Michigan’s Eva Feldman, M.D.